Cantheon Capital

Cantheon Capital is a private equity firm located in Dallas, Texas, focused on providing financial support to early and mid-stage companies in the biotechnology sector. The firm specializes in assisting businesses that are developing novel FDA-registered pharmaceuticals, particularly in the Cannabinoid and Entheogen space. Cantheon Capital employs various investment strategies, including convertible debt, traditional debt, and growth capital, to help these companies advance through clinical trials and achieve their developmental objectives.